Jane Street

Jane Street Portfolio holdings

AUM $85.6B
1-Year Est. Return 6.03%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Quarter Est. Return
1 Year Est. Return
+6.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$85.6B
AUM Growth
+$23.7B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7,327
New
Increased
Reduced
Closed

Top Buys

1 +$2.21B
2 +$1.15B
3 +$1.13B
4
CRWV
CoreWeave Inc
CRWV
+$993M
5
AVGO icon
Broadcom
AVGO
+$715M

Top Sells

1 +$929M
2 +$699M
3 +$670M
4
TMUS icon
T-Mobile US
TMUS
+$536M
5
NDAQ icon
Nasdaq
NDAQ
+$535M

Sector Composition

1 Technology 25.63%
2 Consumer Discretionary 10.01%
3 Financials 9.31%
4 Healthcare 8.53%
5 Industrials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JVA icon
5576
Coffee Holding Co
JVA
$20.2M
$60.8K ﹤0.01%
13,306
-13,974
DSM
5577
BNY Mellon Strategic Municipal Bond Fund
DSM
$301M
$60.5K ﹤0.01%
+10,215
NCNA
5578
NuCana
NCNA
$15.5M
$59.2K ﹤0.01%
+12,763
INUV icon
5579
Inuvo
INUV
$43.2M
$59.2K ﹤0.01%
+16,869
ENTX icon
5580
Entera Bio
ENTX
$99.1M
$58.6K ﹤0.01%
30,528
+20,341
BDN
5581
Brandywine Realty Trust
BDN
$523M
$58.1K ﹤0.01%
13,943
-225,314
DAVEW icon
5582
Dave Inc Warrants
DAVEW
$7.67M
$57.9K ﹤0.01%
53,388
-2,210
QNCX icon
5583
Quince Therapeutics
QNCX
$235M
$57.3K ﹤0.01%
+35,160
UFI icon
5584
UNIFI
UFI
$65.2M
$57K ﹤0.01%
11,975
-1,298
INAB icon
5585
IN8bio
INAB
$7.79M
$56.8K ﹤0.01%
+26,182
CMMB
5586
Chemomab Therapeutics
CMMB
$12.7M
$56.6K ﹤0.01%
21,511
+16,369
FNGR icon
5587
FingerMotion
FNGR
$91.2M
$56.1K ﹤0.01%
35,493
+25,065
MFM
5588
MFS Municipal Income Trust
MFM
$222M
$55.9K ﹤0.01%
10,378
-8,138
ZYXI icon
5589
Zynex
ZYXI
$20.1M
$54.7K ﹤0.01%
37,757
-55,582
ARTW icon
5590
Arts-Way Manufacturing Co
ARTW
$12.6M
$54.1K ﹤0.01%
+21,820
GEG icon
5591
Great Elm Group
GEG
$87.5M
$53.7K ﹤0.01%
+21,930
CETY icon
5592
Clean Energy Technologies
CETY
$7.09M
$52K ﹤0.01%
+12,183
SOL
5593
DELISTED
Emeren Group
SOL
$51.9K ﹤0.01%
27,480
-68,461
HERZ
5594
Herzfeld Credit Income Fund
HERZ
$40.8M
$51.4K ﹤0.01%
+21,605
BARK icon
5595
BARK
BARK
$113M
$51.4K ﹤0.01%
61,825
-300,256
WRAP icon
5596
Wrap Technologies
WRAP
$129M
$50.4K ﹤0.01%
23,237
-224
PRLD icon
5597
Prelude Therapeutics
PRLD
$122M
$50.1K ﹤0.01%
34,822
-56,931
SKYE icon
5598
Skye Bioscience
SKYE
$34.6M
$50.1K ﹤0.01%
+12,737
HTCR icon
5599
HeartCore Enterprises
HTCR
$9.46M
$49.4K ﹤0.01%
+60,959
VYNE icon
5600
VYNE Therapeutics
VYNE
$12.5M
$49.3K ﹤0.01%
147,120
+22,298